AbstractCancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in normal tissues and aberrant expression in different types of tumors being considered promising candidates for immunotherapy. We used the alignment between EST sequences and the human genome sequence to identify novel CT genes. By examining the EST tissue composition of known CT clusters we defined parameters for the selection of 1184 EST clusters corresponding to putative CT genes. The expression pattern of 70 CT gene candidates was evaluated by RT-PCR in 21 normal tissues, 17 tumor cell lines and 160 primary tumors. We were able to identify 4 CT genes expressed in different types of tumors. The presence of antibodies against the protein e...
International audienceCancer-testis (CT) Ags are attractive targets for immunotherapeutic strategies...
Copyright: Copyright 2005 Elsevier B.V., All rights reserved.Genes expressed both in normal testis a...
Cancer/Testis Antigens (CTAs) are a promising class of tumor antigens that have a limited expression...
Cancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in norma...
The potency of the immune response has still to be harnessed effectively to combat human cancers. Ho...
The identification of cancer-specific biomolecules is of fundamental importance to the development o...
The identification of tumour antigens (TAs) represents an ongoing challenge to the development of no...
To determine the expression of cancer testis (CT) genes and antibody responses in a nonselected popu...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
In the context of cancer immunotherapy, agents that target the immune system to cancer cells need to...
Immunotherapy for cancer has been recognized as the fourth therapeutic method after surgery, radioth...
Tumours frequently activate genes whose expression is otherwise biased to the testis, collectively k...
Cancer/testis antigens (CTAs) are a kind of antigens that their expression mostly is restricted in t...
Serum autoantibody to cancer/testis antigens (CTAs) is a critical biomarker that reflects the antitu...
International audienceCancer-testis (CT) Ags are attractive targets for immunotherapeutic strategies...
Copyright: Copyright 2005 Elsevier B.V., All rights reserved.Genes expressed both in normal testis a...
Cancer/Testis Antigens (CTAs) are a promising class of tumor antigens that have a limited expression...
Cancer/testis Antigens (CTAs) are immunogenic proteins with a restricted expression pattern in norma...
The potency of the immune response has still to be harnessed effectively to combat human cancers. Ho...
The identification of cancer-specific biomolecules is of fundamental importance to the development o...
The identification of tumour antigens (TAs) represents an ongoing challenge to the development of no...
To determine the expression of cancer testis (CT) genes and antibody responses in a nonselected popu...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
Cancer/Testis (CT) genes, normally expressed in germ line cells but also activated in a wide range o...
In the context of cancer immunotherapy, agents that target the immune system to cancer cells need to...
Immunotherapy for cancer has been recognized as the fourth therapeutic method after surgery, radioth...
Tumours frequently activate genes whose expression is otherwise biased to the testis, collectively k...
Cancer/testis antigens (CTAs) are a kind of antigens that their expression mostly is restricted in t...
Serum autoantibody to cancer/testis antigens (CTAs) is a critical biomarker that reflects the antitu...
International audienceCancer-testis (CT) Ags are attractive targets for immunotherapeutic strategies...
Copyright: Copyright 2005 Elsevier B.V., All rights reserved.Genes expressed both in normal testis a...
Cancer/Testis Antigens (CTAs) are a promising class of tumor antigens that have a limited expression...